2023
Discrepant Volume-cost Relationship Of Septal Reduction Therapies For The Treatment Of Obstructive Hypertrophic Cardiomyopathy
Altibi A, Ghanem F, Masri A. Discrepant Volume-cost Relationship Of Septal Reduction Therapies For The Treatment Of Obstructive Hypertrophic Cardiomyopathy. Journal Of Cardiac Failure 2023, 29: 639-640. DOI: 10.1016/j.cardfail.2022.10.228.Peer-Reviewed Original ResearchAlcohol septal ablationSeptal reduction therapyObstructive hypertrophic cardiomyopathyHigh-volume centersSeptal myectomyTertile of hospital volumeLow-volume centersNational Readmission DatabaseSeptal ablationHypertrophic cardiomyopathyTreatment of obstructive hypertrophic cardiomyopathyReduction therapyAlcohol septal ablation proceduresInverse volume-cost relationshipHospital volumeProcedure volumeHospital procedure volumeMedical therapyAnnual procedure volumeReadmissions DatabaseAverage annual chargesInflation-adjusted chargesVolume-cost relationshipHospital costsTherapy
2019
Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death A Systematic Review and Meta-Analysis
Masri A, Altibi A, Erqou S, Zmaili M, Saleh A, Al-Adham R, Ayoub K, Baghal M, Alkukhun L, Barakat A, Jain S, Saba S, Adelstein E. Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death A Systematic Review and Meta-Analysis. JACC Clinical Electrophysiology 2019, 5: 152-161. PMID: 30784684, PMCID: PMC6383782, DOI: 10.1016/j.jacep.2018.11.011.Peer-Reviewed Original ResearchConceptsRandomized controlled trialsWearable cardioverter-defibrillator therapyWearable cardioverter-defibrillatorVEST trialSudden cardiac deathDerSimonian and Laird methodCardiac deathMonths of follow-upPrevention of sudden cardiac deathA systematic reviewPrimary preventionOutcomes of patientsCardioverter-defibrillator therapyLaird methodObservational studyMeta-analysisGoogle ScholarIschemic cardiomyopathyMedical therapyFollow-upCardioverter-defibrillatorPreventionTherapyVestPersons